NCT05151354

Brief Summary

This study investigates whether within- and between-patient effects of attachment moderate the association between self-disclosure and psychotherapy outcome.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 15, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

December 9, 2021

Completed
Last Updated

December 9, 2021

Status Verified

November 1, 2021

Enrollment Period

6.7 years

First QC Date

November 15, 2021

Last Update Submit

November 25, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Symptom Checklist Short Form (SCL-K11)

    Symptom measure

    for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)

Secondary Outcomes (2)

  • Relationship Questionnaire 2 (RQ-2)

    for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)

  • Inpatient and day clinic experiences questionnaire (IDES)

    for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)

Interventions

Patients receive 8 weeks of inpatient psychotherapeutic treatment. Treatment consists of individual and group psychodynamic psychotherapy, as well as an individual combination of art, music, body-oriented and relaxation therapies, which are also carried out in group settings. Treatments is provided by an interdisciplinary team of psychotherapists with a medical or psychology degree, art of music therapists, social workers, physiotherapists and specialist nurses.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of patients undergoing inpatient treatment at the university hospital Heidelberg.

You may qualify if:

  • patients of at least 18 years of age
  • treated at the inpatient unit of a hospital for psychosomatic medicine
  • provided measurements of symptoms, attachment style, and self-disclosure for at least one measurement occasion

You may not qualify if:

  • bipolar, acute psychotic or substance abuse disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Psychotherapy

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Study Officials

  • Ulrike Dinger, Prof

    University Hospital Heidelberg

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 15, 2021

First Posted

December 9, 2021

Study Start

January 1, 2015

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

December 9, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share